Venture-Backed Startups
71,935 companies with verified investor relationships.
0 investors
Athletic Brewing produces craft non-alcoholic beer in multiple styles including IPAs, pale ales, radlers, and sours for consumers seeking flavorful beverages without alcohol. The company markets itself as the #1 selling craft non-alcoholic beer brand and holds B-corp certification.
1 investor
0 investors
Momento is a mobile application that automatically organizes photos, events, and locations into a structured private memory timeline for sports and music fans. The platform helps users capture, share, and relive moments from concerts, games, trips, and everyday experiences.
2 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Athlytic connects brands with athlete influencers and creators to build experiential marketing campaigns targeting sports enthusiasts and Gen Z audiences. The company combines influencer partnerships, experiential activations, and AI-powered media targeting to drive brand engagement.
4 investors
BlackBerry AtHoc is a critical event management platform that consolidates fragmented signals into coordinated action across teams, systems, and agencies for mission-critical organizations. It provides real-time situational awareness, automated workflows, mobile-enabled operations, and secure communication to enable faster decisions and coordinated response during high-pressure incidents.
1 investor
At Home Harmony provides in-home primary care and specialist services for older adults with complex medical needs, including chronic disease management, dementia support, and pharmacy services delivered directly to patients' homes.
2 investors
Montreal-based leader in Quebec's deathcare market, providing funeral, cremation, and cemetery services and merchandise across the Montreal and Quebec City metro areas.
1 investor
0 investors
0 investors
Athos Medical Technology develops inhalation drug delivery technology that increases the efficiency of inhaled medications reaching the lungs, with studies showing 94% of the inhaled dose entering systemic circulation compared to the current 33% standard. The technology targets improvement in treatment efficacy and reduced adverse effects for patients requiring inhaled medications.
1 investor
Ati Robotics develops autonomous mobile robots (AMRs) for industrial facilities with demanding material movement requirements. The company provides full-stack robotics solutions including hardware, software, and deployment support with ongoing operational accountability.
3 investors
2 investors
Cloud-based SaaS platform using AI and machine learning to help life insurers make informed business decisions.
2 investors
0 investors
1 investor
0 investors